MedPath

PAION Deutschland GmbH

🇩🇪Germany
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.paion.com

Clinical Trials

10

Active:7
Completed:2

Trial Phases

2 Phases

Phase 1:2
Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (50.0%)
Phase 2
2 (50.0%)

Desmoteplase in Acute Ischemic Stroke (DIAS)

Phase 2
Completed
Conditions
Stroke
Interventions
Drug: Placebo
First Posted Date
2008-03-19
Last Posted Date
2008-03-19
Lead Sponsor
PAION Deutschland GmbH
Target Recruit Count
104
Registration Number
NCT00638781
Locations
🇩🇪

Prof. Dr. Werner Hacke, Heidelberg, Germany

Dose Escalation of Desmoteplase in Acute Ischemic Stroke (DEDAS)

Phase 1
Completed
Conditions
Stroke
Interventions
Drug: Placebo
First Posted Date
2008-03-19
Last Posted Date
2008-03-19
Lead Sponsor
PAION Deutschland GmbH
Target Recruit Count
38
Registration Number
NCT00638248

Tolerability of Enecadin (INN) in Acute Ischemic Stroke Trial - TEST

Phase 2
Terminated
Conditions
Stroke
Interventions
Drug: Placebo
First Posted Date
2006-05-31
Last Posted Date
2008-05-22
Lead Sponsor
PAION Deutschland GmbH
Target Recruit Count
24
Registration Number
NCT00331721
Locations
🇦🇹

Investigational Site 1, Linz, Austria

🇦🇹

Investigational Site 2, Linz, Austria

🇩🇪

Investigational Site, Wiesbaden, Germany

and more 1 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.